ESPR Research and Charts

ESPR - Esperion Therapeutics Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-12 (Delayed quote data 2025-04-04)

Last 1.23	Change ⇓ -0.06 (-4.65%)	Volume 5,280,258
	Open 1.28	High 1.30	Low 1.17

8EMA (Daily) 1.41	40EMA (Daily) 1.65	50EMA (Daily) 1.71	STO (Daily) 8.707	MACD Hist (Daily) -0.060
8EMA (Weekly) 1.603	40EMA (Weekly) 2.00	50EMA (Weekly) 2.07	STO (Weekly) 7.068	MACD Hist (Weekly) -0.153


Company Profile
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol. The firm has Business of researching, developing and commercializing therapies for the treatment of patients with the elevated LDL-C operating segment.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.